The transaction, the terms of which were not disclosed, represented the end of a four-year journey for the Pittsburgh-based health system. It also makes UPMC part of a rising trend of health systems looking to their commercialization and venture capital arms to develop new sources of revenue to offset financial challenges. Once proven, the technology can be spun off or sold.